Divi's Laboratories

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue1,9741,8101,9531,9022,338
Expenses1,5061,3321,4891,4121,638
EBITDA555.00571.00559.00585.00796.00
EBIT468.00478.00465.00490.00702.00
Profit Before Tax468.00478.00464.00490.00700.00
Net Profit319.00345.00342.00358.00531.00
Financial Ratios
Operating Profit Margin29.09%33.01%29.93%32.36%35.24%
Net Profit Margin16.72%19.94%18.31%19.80%23.51%
Earning Per Share (Diluted)12.0112.9912.8913.5019.99
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ